Wenke Cheng

1.3k total citations
45 papers, 785 citations indexed

About

Wenke Cheng is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Wenke Cheng has authored 45 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Wenke Cheng's work include Blood Pressure and Hypertension Studies (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Cardiovascular Function and Risk Factors (5 papers). Wenke Cheng is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Cardiovascular Function and Risk Factors (5 papers). Wenke Cheng collaborates with scholars based in China, Germany and Poland. Wenke Cheng's co-authors include Siwei Chen, Chong Yang, Zhen Zhang, Weijun Liu, Huachun Pan, Shumin Yang, Chunhua Xu, Dongfang Li, Zhou Liu and Rong Sun and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and Coordination Chemistry Reviews.

In The Last Decade

Wenke Cheng

43 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenke Cheng China 17 265 148 135 111 108 45 785
Zekeriya Kaya Türkiye 16 285 1.1× 208 1.4× 175 1.3× 198 1.8× 104 1.0× 50 927
Amy C. Alman United States 15 144 0.5× 100 0.7× 115 0.9× 122 1.1× 111 1.0× 62 635
M. Abdullah Said Netherlands 11 312 1.2× 121 0.8× 130 1.0× 108 1.0× 176 1.6× 20 943
Sheng-Yong Dong China 12 182 0.7× 82 0.6× 177 1.3× 105 0.9× 189 1.8× 30 835
İbrahim Keleş Türkiye 16 135 0.5× 194 1.3× 65 0.5× 201 1.8× 89 0.8× 93 900
Silvia Lai Italy 19 161 0.6× 85 0.6× 144 1.1× 49 0.4× 74 0.7× 104 1.1k
Jing Bai China 13 136 0.5× 87 0.6× 99 0.7× 57 0.5× 122 1.1× 44 725
Zhendong Liu China 22 458 1.7× 261 1.8× 112 0.8× 110 1.0× 133 1.2× 83 1.3k
Arti D. Shah United States 10 121 0.5× 176 1.2× 153 1.1× 243 2.2× 88 0.8× 17 785
Toshiki Maeda Japan 16 140 0.5× 182 1.2× 34 0.3× 107 1.0× 57 0.5× 89 653

Countries citing papers authored by Wenke Cheng

Since Specialization
Citations

This map shows the geographic impact of Wenke Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenke Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenke Cheng more than expected).

Fields of papers citing papers by Wenke Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenke Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenke Cheng. The network helps show where Wenke Cheng may publish in the future.

Co-authorship network of co-authors of Wenke Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenke Cheng. A scholar is included among the top collaborators of Wenke Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenke Cheng. Wenke Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cheng, Wenke, Xianlin Zhang, Jie Shi, et al.. (2025). Stress hyperglycemia ratio and risk of incident myocardial infarction in the general population: a large-scale cohort study. Frontiers in Nutrition. 12. 1601137–1601137.
3.
Cheng, Wenke, et al.. (2024). Sex Differences in “Life’s Essential 8” Cardiovascular Health and Type 2 Diabetes Mellitus Risk Across Menopause Stages. The Journal of Clinical Endocrinology & Metabolism. 110(3). 787–800. 1 indexed citations
4.
Cheng, Wenke, et al.. (2024). Galectin-3 Levels and Long-Term All-Cause Mortality and Hospitalization in Heart Failure Patients: A Meta-Analysis. ESC Heart Failure. 11(5). 2566–2577. 6 indexed citations
5.
Pan, Huachun, Shumin Yang, Lun Gao, et al.. (2024). At the crossroad of nanotechnology and cancer cell membrane coating: Expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting. Coordination Chemistry Reviews. 506. 215712–215712. 23 indexed citations
6.
Cheng, Wenke, et al.. (2024). Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank. Journal of Cancer Research and Clinical Oncology. 150(8). 399–399. 6 indexed citations
7.
Yu, Wen‐Chung, et al.. (2024). Association of triglyceride-glucose index and its combination with obesity indicators in predicting the risk of aortic aneurysm and dissection. Frontiers in Nutrition. 11. 1454880–1454880. 5 indexed citations
8.
9.
Cheng, Wenke, et al.. (2023). Predictive value of estimated pulse wave velocity for cardiovascular and all-cause mortality in individuals with obesity. Diabetology & Metabolic Syndrome. 15(1). 40–40. 11 indexed citations
10.
11.
Pan, Huachun, et al.. (2023). Estimated pulse wave velocity is associated with all-cause and cardio-cerebrovascular disease mortality in stroke population: Results from NHANES (2003–2014). Frontiers in Cardiovascular Medicine. 10. 1140160–1140160. 21 indexed citations
12.
Xu, Chunhua, et al.. (2023). System inflammation response index: a novel inflammatory indicator to predict all-cause and cardiovascular disease mortality in the obese population. Diabetology & Metabolic Syndrome. 15(1). 195–195. 36 indexed citations
13.
Pan, Huachun, Shumin Yang, Wenke Cheng, Qiang Cai, & Quazi T.H. Shubhra. (2023). Alternate-day fasting exacerbates doxorubicin cardiotoxicity in cancer chemotherapy. Trends in Endocrinology and Metabolism. 34(7). 392–394. 11 indexed citations
14.
Cheng, Wenke, Georg Fuernau, Steffen Desch, et al.. (2022). Circulating Monocyte Chemoattractant Protein-1 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Substudy of SHOCK-COOL Trial. Journal of Cardiovascular Development and Disease. 9(8). 280–280. 4 indexed citations
15.
Cheng, Wenke, Georg Fuernau, Steffen Desch, et al.. (2022). Circulating Galectin-3 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Sub-Study of the SHOCK-COOL Trial. Journal of Clinical Medicine. 11(23). 7168–7168. 9 indexed citations
16.
Cheng, Wenke, Lili Wang, & Siwei Chen. (2022). Differences in Lipid Profiles and Atherogenic Indices Between Hypertensive and Normotensive Populations: A Cross-Sectional Study of 11 Chinese Cities. Frontiers in Cardiovascular Medicine. 9. 887067–887067. 9 indexed citations
17.
Chen, Siwei & Wenke Cheng. (2022). Relationship Between Lipid Profiles and Hypertension: A Cross-Sectional Study of 62,957 Chinese Adult Males. Frontiers in Public Health. 10. 895499–895499. 37 indexed citations
18.
19.
Liu, Zhou, et al.. (2019). Relations of Anemia With the All-Cause Mortality and Cardiovascular Mortality in General Population: A Meta-Analysis. The American Journal of the Medical Sciences. 358(3). 191–199. 32 indexed citations
20.
Zhang, Zhen, et al.. (2018). Oral bisphosphonates and incidence of cancers in patients with osteoporosis: a systematic review and meta-analysis. Archives of Osteoporosis. 14(1). 1–1. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zekeriya Kaya Breakdown of academic impact, for papers by Amy C. Alman Breakdown of academic impact, for papers by M. Abdullah Said Breakdown of academic impact, for papers by Sheng-Yong Dong Breakdown of academic impact, for papers by İbrahim Keleş Breakdown of academic impact, for papers by Silvia Lai Breakdown of academic impact, for papers by Jing Bai Breakdown of academic impact, for papers by Zhendong Liu Breakdown of academic impact, for papers by Arti D. Shah Breakdown of academic impact, for papers by Toshiki Maeda
Rankless by CCL
2026